Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07477275

Combination of Oral and Topical Whitening Agents for Reducing Skin Pigmentation

Combination of Oral and Topical Whitening Agents for Reducing Skin Pigmentation in Healthy Women: A Randomized Controlled Trial

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
68 (estimated)
Sponsor
USMARI Research & Innovation Centre · Industry
Sex
Female
Age
30 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to evaluate the safety and efficacy of a combination use of oral supplement and topical serum in improving skin pigmentation in healthy women. The main questions it aims to answer are: Does combination use able to reduce the dark spot? Is there any adverse effect associate with the product use?

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENToral supplementOral supplement need to be consume for 12 weeks. Subject need to consume the capsule once daily, during the first week. After the first week, if there are no adverse effects, they need to consume the capsule twice daily (normal dosage).
OTHERRetinol serumSerum need to be apply daily at night only, in a thin layer. The application schedule is as follows: in week 1, once a week; in week 2, twice a week (if no adverse reactions occur in week 1, such as skin dryness); in weeks 3 and 4, twice a week; and from week 4 onwards until the study is completed, three times per week.

Timeline

Start date
2024-12-01
Primary completion
2026-04-30
Completion
2026-04-30
First posted
2026-03-17
Last updated
2026-03-17

Locations

1 site across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT07477275. Inclusion in this directory is not an endorsement.

Combination of Oral and Topical Whitening Agents for Reducing Skin Pigmentation (NCT07477275) · Clinical Trials Directory